Your browser doesn't support javascript.
loading
Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models.
Su, Jinpeng; Brunner, Livia; Ates Oz, Edanur; Sacherl, Julia; Frank, Geraldine; Kerth, Helene Anne; Thiele, Frank; Wiegand, Marian; Mogler, Carolin; Aguilar, Julio Cesar; Knolle, Percy A; Collin, Nicolas; Kosinska, Anna D; Protzer, Ulrike.
Afiliación
  • Su J; Institute of Virology, School of Medicine, Technical University of Munich / Helmholtz Center Munich, Munich, Germany.
  • Brunner L; Vaccine Formulation Institute, Plan-Les-Ouates, Switzerland.
  • Ates Oz E; Institute of Virology, School of Medicine, Technical University of Munich / Helmholtz Center Munich, Munich, Germany.
  • Sacherl J; Institute of Virology, School of Medicine, Technical University of Munich / Helmholtz Center Munich, Munich, Germany.
  • Frank G; Vaccine Formulation Institute, Plan-Les-Ouates, Switzerland.
  • Kerth HA; Institute of Virology, School of Medicine, Technical University of Munich / Helmholtz Center Munich, Munich, Germany; Center for Genetic Engineering and Biotechnology, Havana, Cuba.
  • Thiele F; Institute of Virology, School of Medicine, Technical University of Munich / Helmholtz Center Munich, Munich, Germany.
  • Wiegand M; Institute of Virology, School of Medicine, Technical University of Munich / Helmholtz Center Munich, Munich, Germany.
  • Mogler C; Institute of Molecular Immunology and Experimental Oncology, Technical University of Munich, Munich, Germany.
  • Aguilar JC; Institute of Pathology, School of Medicine, Technical University of Munich, Munich, Germany.
  • Knolle PA; Center for Genetic Engineering and Biotechnology, Havana, Cuba; German Center for Infection Research (DZIF), Munich partner site, Munich, Germany.
  • Collin N; Vaccine Formulation Institute, Plan-Les-Ouates, Switzerland.
  • Kosinska AD; Institute of Virology, School of Medicine, Technical University of Munich / Helmholtz Center Munich, Munich, Germany; German Center for Infection Research (DZIF), Munich partner site, Munich, Germany. Electronic address: anna.kosinska@tum.de.
  • Protzer U; Institute of Virology, School of Medicine, Technical University of Munich / Helmholtz Center Munich, Munich, Germany; German Center for Infection Research (DZIF), Munich partner site, Munich, Germany. Electronic address: protzer@tum.de.
J Hepatol ; 78(4): 717-730, 2023 04.
Article en En | MEDLINE | ID: mdl-36634821
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra Hepatitis B / Hepatitis B Crónica Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra Hepatitis B / Hepatitis B Crónica Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Países Bajos